| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.0M | -23.9% |
| Cost of Revenue | $2.1M | -23.6% |
| Gross Profit | $871K | -24.7% |
| R&D Expense | $9.6M | +40.0% |
| SG&A Expense | $7.0M | +26.6% |
| Operating Income | -$18.1M | -45.0% |
| Pre-tax Income | $17.0M | +244.8% |
| Income Tax | $0 | — |
| Net Income | -$17.0M | -44.8% |
| EPS (Basic) | -$1.07 | -3.9% |
| EPS (Diluted) | -$1.07 | -3.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.7M | +41.4% |
| Accounts Receivable | $278K | -81.6% |
| Inventory | $50K | -75.4% |
| Current Assets | $27.5M | +32.3% |
| Total Assets | $29.0M | +22.4% |
| Current Liabilities | $3.0M | -9.0% |
| Total Liabilities | $3.6M | -34.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.7M | -66.8% |
| Capital Expenditures | $56K | +5.7% |
| Investing Cash Flow | $254K | -96.7% |
| Financing Cash Flow | $21.1M | +115.3% |
| Free Cash Flow | -$13.8M | -66.4% |
| $25.4M |
| +39.4% |